Weekly Mass Torts Bulletin 2023-February-20
According to a new study, opioid addiction could be reduced by developing medicines that block the kappa-opioid receptor.
Weekly Mass Torts Bulletin 2023-February-13
Marinette County, as one of the plaintiffs in a case against a dozen pharmaceutical corporations, could collect a roughly $2 million opioid settlement over an 18-year period.
Personal Injury News: Pick Of Last Month: Feb-2023
After being accused of doing unneeded procedures, a Conyers doctor agreed to pay almost $2 million in settlements.
Weekly Mass Torts Bulletin 2023-February-6
A US appeals court has found that Johnson & Johnson's use of bankruptcy to deal with growing talc litigation would create a legal blind zone.
Weekly Mass Torts Bulletin 2023-January-30
The federal court in Florida hearing over a slew of earplug claims filed against 3M has called off efforts to arrange a settlement.
Weekly Mass Torts Bulletin 2023-January-23
Local officials now have new allies in their fight against Travis County's escalating problem of deadly opioid overdoses.
Weekly Mass Torts Bulletin 2023-January-16
Teva Pharmaceuticals just needs two more states to achieve agreements or agree to engage in a settlement accord with the generics giant for its participation in the US opioid epidemic.
Weekly Mass Torts Bulletin 2023-January-9
According to the attorney general, Oklahoma has reached settlement agreements worth more than $226 million with three large drugstore chains and one opioid manufacturer.
Personal Injury News: Pick Of Last Month: Jan-2023
Two healthcare providers in Santa Barbara and San Luis Obispo counties, including Dignity Health, have agreed to pay $22.5 million in settlement arrangements to resolve charges that they violated federal and state law by submitting phoney invoices to Medicaid.
Weekly Mass Torts Bulletin 2023-January-2
Local governments in Northwest Florida and Miami-Dade County have filed lawsuits against the multinational consulting company McKinsey & Company for prior work in assisting with the marketing of opioids.
Weekly Mass Torts Bulletin 2022-December-26
Philips has completed safety studies on several of its equipment nearly two years after first publicly raising concerns about the possible disintegration of the polyester-based polyurethane foam included in many of its CPAP and BiPAP machines and other breathing devices.
Weekly Mass Torts Bulletin 2022-December-19
In its opening brief to the 7th U.S. Circuit Court of Appeals, 3M claimed that the judge misunderstood precedent, ignored significant evidence, and adopted an unduly narrow construction of his inherent jurisdiction to block action against 3M.